Skip to content

Amlodipine besylate

DRUG15 trials

Sponsors

SK Chemicals Co., Ltd., Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Teva Pharmaceuticals USA, Torrent Pharmaceuticals Limited, Merck Sharp & Dohme LLC

Conditions

Chronic Hypertension in PregnancyDyslipidemiaElevated Plasma Homocysteine (Hcy≥10µmol/L)Essential HypertensionHealthyHeart Failure With Preserved Ejection FractionHemodialysisHigh Blood Pressure

Phase 1

Phase 3

Phase 4

A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk
CompletedNCT00412113
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Dyslipidemia, Hypertension
Start: 2007-01-31End: 2008-04-30Updated: 2021-02-11
Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation
CompletedNCT02353806
University of Texas Southwestern Medical CenterChronic Hypertension in Pregnancy
Start: 2015-01-31End: 2016-09-30Updated: 2019-02-06
Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness
TerminatedNCT02940548
Jing LiuHypertension
Start: 2016-12-31End: 2020-12-31Updated: 2022-04-29
BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF
CompletedNCT04434664
University of PennsylvaniaHeart Failure With Preserved Ejection Fraction, Hypertension
Start: 2021-12-01End: 2024-12-20Updated: 2026-01-30
China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
RecruitingNCT04974138
Shenzhen Ausa Pharmed Co.,LtdElevated Plasma Homocysteine (Hcy≥10µmol/L), Hypertension, Insufficient Plasma Folate Levels (<12ng/mL) +1
Start: 2024-08-22End: 2030-06-30Target: 32000Updated: 2025-02-26
China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
RecruitingNCT04974151
Shenzhen Ausa Pharmed Co.,LtdHypertension, MTHFR 677 TT Genotype
Start: 2024-08-22End: 2029-06-30Target: 24000Updated: 2025-02-26
Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN)
WithdrawnNCT05275907
Northwestern UniversityHigh Blood Pressure, Liver Transplant, Renal Function Abnormal
Start: 2022-07-12End: 2023-10-04Updated: 2023-10-13

Unknown Phase

Related Papers